| Identification | Back Directory | [Name]
renzapride | [CAS]
109872-41-5 | [Synonyms]
ATL1251
AZM-112
ATL-1251
BRL-24924
Renzapride HCl
Renzapride hydrochloride
Dalotutumab (Renzapride)
4-amino-N-(1-azabicyclo[3.3.1]nonan-4-yl)-5-chloro-2-methoxybenzamide,hydrochloride
4-amino-N-[(4R,5S)-1-azabicyclo[3.3.1]nonan-4-yl]-5-chloro-2-methoxybenzamide:hydrochloride | [Molecular Formula]
C16H23Cl2N3O2 | [MDL Number]
MFCD18782667 | [MOL File]
109872-41-5.mol | [Molecular Weight]
360.279 |
| Hazard Information | Back Directory | [Uses]
Renzapride hydrochloride is a benzamide that inhibits irritable bowel syndrome and has antagonistic activity at 5-HT(3) receptors and agonistic activity at 5-HT(4) receptors. Renzapride hydrochloride also exhibits antagonistic activity at 5-HT(2B) receptors and has a certain affinity for 5-HT(2A) and 5-HT(2C) receptors[1]. | [References]
[1] Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome |
|
|